Sun Pharmaceutical Industries’ manufacturing facility in Halol in Gujarat is undergoing a surprise audit by the US Food and Drug Administration (US FDA). The move may have been triggered by a number of recent recalls from the plant. The plant contributes to around 40% of US sales and around 25% of consolidated profit of the company.
Real Time News & Trading Trends Keep Liking #EpicResearch
Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+
For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH
05:14
Unknown
Posted in:
0 comments:
Post a Comment